ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
Cedars-Sinai Medical Center at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
Cedars-Sinai Medical Center takes part in 3 sessions at ASHI 2026 in Montréal. Its work centers on MICA antibodies, from the amino acid residues they recognize to a de novo donor-specific MICA antibody behind antibody-mediated rejection in a lung transplant. It also pilots the KIR Complete MX reagent with Oxford Nanopore sequencing.
| Organization | ASHI 2026 Attendance |
|---|---|
Cedars-Sinai Medical Center Los Angeles, CA | |
Nonprofit academic medical center and hospital with research programs and a transplant center covering heart, kidney, liver and lung transplantation. | Poster Dominant Amino Acid Residues of MICA Recognized by Antibodies HLA antibodies, crossmatching and eplets Poster Pilot Study of the KIR Complete MX Reagent with Oxford Nanopore Sequencing HLA typing, sequencing and genotyping Poster De Novo Donor-Specific MICA Antibody Causes Antibody-Mediated Rejection in Lung Transplant HLA antibodies, crossmatching and epletsSolid organ transplantation |
Find decision makers at Cedars-Sinai Medical Center
Tell us what you sell and we’ll find the people at Cedars-Sinai Medical Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction